MENU
+Compare
SVRA
Stock ticker: NASDAQ
AS OF
Oct 8, 04:59 PM (EDT)
Price
$3.46
Change
+$0.03 (+0.87%)
Capitalization
599.74M

SVRA Savara Forecast, Technical & Fundamental Analysis

Savara Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SVRA with price predictions
Oct 07, 2025

SVRA's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for SVRA moved out of overbought territory on September 11, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SVRA as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SVRA turned negative on September 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SVRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SVRA broke above its upper Bollinger Band on September 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where SVRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for SVRA moved above the 200-day moving average on September 12, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SVRA advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 168 cases where SVRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.978) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (342.085).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SVRA is expected to report earnings to fall 7.14% to -12 cents per share on November 06

Savara SVRA Stock Earnings Reports
Q3'25
Est.
$-0.13
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.02
Q3'24
Est.
$-0.11
The last earnings report on August 13 showed earnings per share of -14 cents, missing the estimate of -11 cents. With 1.29M shares outstanding, the current market capitalization sits at 599.74M.
A.I. Advisor
published General Information

General Information

a pharmaceuticals developer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1717 Langhorne Newtown Road
Phone
+1 512 614-1848
Employees
37
Web
https://www.savarapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGRSX9.92N/A
N/A
Principal Global Real Estate Sec R6
BROIX23.38N/A
N/A
BlackRock Advantage International Instl
CFWIX31.27N/A
N/A
Calvert Global Water I
VRSCX25.39N/A
N/A
Voya SmallCap Opportunities Port R6
LHCAX20.48N/A
N/A
Lord Abbett Health Care A

SVRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-0.87%
RCKT - SVRA
61%
Loosely correlated
-1.26%
PRTA - SVRA
46%
Loosely correlated
+3.14%
OCUL - SVRA
39%
Loosely correlated
+5.01%
AMLX - SVRA
38%
Loosely correlated
+6.30%
RVMD - SVRA
37%
Loosely correlated
-0.02%
More